Results 221 to 230 of about 288,159 (307)
MIC and IC50 for the tested microbial species using the formulation
MIC and IC50 for the tested microbial species using the ...
openaire +1 more source
596 IC50 determination for receptor-targeted compounds and downstream signaling
H. Salimi-Moosavi +5 more
openaire +1 more source
Redox responsive mesoporous silica nanoparticles (MSNs) were engineered to deliver gemcitabine (Gem) and cisplatin (cisPt) at defined ratios to overcome chemoresistance in pancreatic ductal adenocarcinoma (PDAC). Optimized Gem MSNs and Gem cisPt MSNs enhanced cytotoxicity in murine and human Gem resistant models, with select formulations inducing ...
Tamanna Binte Huq +5 more
wiley +1 more source
A Lipid‐Conjugation Strategy for Intracellular Reactive Oxygen Species Control in Hepatic Cells
A lipid conjugation strategy anchors a manganese Salen complex within phospholipid membranes, yielding stable, catalytically active liposomes. These lipid–metal assemblies efficiently degrade reactive oxygen species (ROS) and enable intracellular redox control in steatotic HepaRG cells, offering a precise route to biomimetic antioxidant design ...
Olav Vestrheim +7 more
wiley +2 more sources
Targeting <i>Leishmania</i> Fe-SOD and Glucose Metabolism with Tripodal and Pyridinacyclophane Polyamines as a Chemotherapeutic Strategy. [PDF]
Martín-Montes Á +10 more
europepmc +1 more source
Mitochondria‐Targeting Moieties Based on N‐Tethered Pyridinium Cations
Pyridinium cations were benchmarked as mitochondria‐targeting moieties in a panel of N‐tethered fluorescent‐, bioactive‐, and inert‐cargo conjugates. 3,5‐Diphenylpyridinium (DPPy+) is a competent triphenylphosphonium (TPP+) surrogate, combining high mitochondria‐targeting efficiency with lower intrinsic effects on mitochondrial function.
Ivan Džajić +27 more
wiley +2 more sources
Targeting Selectivity: Improving Golgi α-Mannosidase II (GMII) Inhibitors Through In Silico Studies. [PDF]
Ledesma NG +4 more
europepmc +1 more source
ROBUST AND RIGOROUS IC50 DETERMINATION FOR PRECLINICAL DRUG DISCOVERY
Letícia Fernanda Alves +6 more
openaire +1 more source

